Aeson Therapeutics

Aeson Therapeutics is a biotechnology company focused on developing next-generation vaccines for emerging viral threats, specifically flaviviruses such as Zika and Dengue. Spun out of Oregon Health & Science University (OHSU), the company leverages the research of Dr. William Messer to create highly effective, live-attenuated vaccine candidates that provide robust and durable immunity. Its lead program, a Zika virus vaccine (OHSU-ZIKV), has advanced into early-stage clinical trials, aiming to address the global need for a safe and effective preventative measure against Zika-related birth defects and neurological complications. Aeson Therapeutics is headquartered in Portland, Oregon, and continues to collaborate with academic and federal partners to expand its infectious disease pipeline.